Roche

News

NICE okays NHS funding for MS and eczema drugs

The UK's NICE endorsed regular NHS funding for big-selling drugs from Roche and Sanofi, changing its mind in guidance for the multiple sclerosis and eczema drugs.

News

Tesaro stock rockets as rumours of Roche takeover abound

Shares in US biotech Tesaro peaked this week amid speculation that Roche is making plans to buy it.

News

Roche to buy rest of genetics firm Foundation Medicine

Roche has made an offer to buy the remaining shares in cancer genetics firm Foundation Medicine (FMI) for $2.4 billion.

News

NICE says 'no' to Roche's Perjeta after breast cancer surger...

NICE consulting on first draft decision

Partner Content

Partner Content

New Speakers from Roche & Imperial College announced for...

Roche to join ADMET conference this July in London

News

Genentech’s Rituxan approved for rare skin disease

The FDA has approved Genentech’s Rituxan (rituximab) for use in adults with moderate-to-severe pemphigus vulgaris (PV), making it the first treatment for the condition in more than 60 years.

NICE okays NHS funding for MS and eczema drugs

Tesaro stock rockets as rumours of Roche takeover abound

Roche to buy rest of genetics firm Foundation Medicine

NICE says 'no' to Roche's Perjeta after breast cancer surger...

New Speakers from Roche & Imperial College announced for...

Genentech’s Rituxan approved for rare skin disease

UK offers meningitis jab to young people after outbreak

Discover a new era of healthcare panel engagement: Grounded ...

Roche

Editor's Picks